- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03936608
ECG for Programming in CRT (EPIC)
Electrocardiogram for Programming in Cardiac Resynchronization Therapy
Patients with heart failure and left bundle branch block benefit from Cardiac Resynchronization Therapy (CRT) that delivers pacing from right ventricle (RV) and left ventricle (LV) synchronously, resulting in electrical ventricular resynchrony followed by revere structural cardiac remodeling and thereby reduced heart failure symptoms, hospitalizations and death. It is not known if programming an individually optimized RV-LV pacing offset to maximize electrical resynchrony can improve benefit from CRT.
The proposed study is a randomized controlled trial in patients undergoing implant of a CRT pacemaker/defibrillator device for clinical indications to evaluate benefit of RV-LV offset programming using electrocardiogram (ECG) vs. standard nominal CRT programming without RV-LV offset. Patients receiving CRT devices will be randomized to either (A) active intervention of programming RV-LV pacing offset to optimize ECG or to (B) active control of nominally programming CRT device without RV- LV offset. The patients will be followed to evaluate change in echocardiogram, quality of life, functional evaluation and a blood marker for heart failure.
Study Overview
Status
Detailed Description
Once the eligibility for the study is determined and patient has consented for participation, all study participants will undergo a baseline evaluation (within 6 weeks prior to 2 weeks after CRT device implant/upgrade). Echocardiogram, quality-of-life questionnaire, 6-minute hall walk, blood test, vital signs, ECGs, device interrogation and baseline demographic and medical history including chart review will be obtained. After CRT device implant/upgrade, participants will undergo physiologic evaluations at various (up to 10 or more) RV-LV offset settings including ECGs and echocardiography. A randomized assignment using a random allocation table in REDCap will be used to program patients to (A) intervention or (B) control RV-LV offset setting. Patients will return for study follow-up between 3-12 months. Follow-up evaluations will include echocardiography, quality-of-life questionnaire, 6-minute hall walk test, blood test, vital signs, ECGs, device interrogation, and follow-up medical history including chart review. The patients will continue to be in extended follow-up through review of their medical charts till the end of the study (12 months from date of CRT implant/upgrade of the the last study participant).
Treatment and control arms: All study patients will receive standard of care clinically indicated medical and device therapy per their treating physicians. After implant of a clinically indicated CRT device or upgrade of a preexisting pacemaker or defibrillator device to CRT system, participants will be randomized 1:1 to treatment arms (A) active intervention of programming individualized RV-LV pacing offset to optimize ECG or to (B) active control of nominally programming CRT device without RV-LV offset. Of note, both intervention and control treatment are active FDA-approved CRT therapies and no investigational device or programming will be used, and no clinically indicated treatment will be withheld from any patient. At any time, if in the judgment of the patient's treating physicians or the research team, any treatment including CRT programming different from the study protocol is necessitated for clinical reasons, the appropriate clinically indicated changes will be made. At the end of the study, if the participant is clinically doing well and the programmed CRT settings are deemed clinically appropriate they will be retained, else the CRT programming may be changed as per standard of care.
Enrolled participants who have a failed or unsatisfactory LV lead implant will not be randomized.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Missouri
-
Saint Louis, Missouri, United States, 63110
- Washington University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients ≥18 years of age who are able to give consent.
- Diagnosis of systolic heart failure.
- Planned to undergo new CRT device implant (or upgrade of preexisting pacemaker or defibrillator device to CRT system) for standard clinical indications.
- Expected to have over 95% heart beats resynchronized with CRT (absence of competing arrhythmias or plans to not immediately activate CRT therapy).
Exclusion Criteria:
- Unable to comply with the study follow-up.
- Life expectancy ≤1 year.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Individualized RV-LV Pacing Offset
|
After CRT device implant, participants will undergo physiologic evaluations at various (up to 10 or more) RV-LV offset settings including ECGs.
The RV-LV offset that optimizes the paced QRS morphology on ECG will be programmed.
|
Active Comparator: No RV-LV Pacing Offset
|
After CRT device implant, participants will undergo physiologic evaluations at various (up to 10 or more) RV-LV offset settings including ECGs.
Nominal standard-of-care CRT programming with no RV-LV offset will be programmed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Primary Outcome is Echocardiographic LV End-systolic Volume.
Time Frame: 3-12 months
|
LV end-systolic volume is a reliable surrogate for clinical outcomes in clinical heart failure trials.
|
3-12 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Amit Noheria, MBBS, SM, Washington University School of Medicine
- Study Director: Sandeep Sodhi, MD, Washington University School of Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201901208
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Electrocardiography
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
University of Toledo Health Science CampusCompletedElectrocardiographyUnited States
-
National University of Natural MedicineUniversity of Manitoba; Oregon Health and Science UniversityCompletedElectrocardiography | Electroencephalography | Respiratory Rate | Surveys and QuestionnairesUnited States
-
Norwegian University of Science and TechnologySykehuset Innlandet HFCompletedElectrocardiography | Catheterization, PeripheralNorway
-
BayerCompletedElectrocardiography | QTc EvaluationSingapore, Australia, Germany, United Kingdom
-
Seoul National University HospitalUnknownBlood Pressure | Electrocardiography | Pediatrics | AccelerometerKorea, Republic of
-
Maxima Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentRecruitingCaesarean Section | Electrocardiography | Cardiotocography | Fetal Monitoring | Non-invasiveNetherlands
-
AmgenCompletedElectrocardiographyUnited States
-
Samsung Medical CenterCompletedChest Pain | ElectrocardiographyKorea, Republic of
-
Samsung Medical CenterCompletedChest Pain | ElectrocardiographyKorea, Republic of